title: Beyond natural antimicrobial peptides: multimeric peptides and other peptidomimetic approaches.
abstract: Naturally occurring antimicrobial peptides (AMPs) present several drawbacks that strongly limit their development into therapeutically valuable antibiotics. These include susceptibility to protease degradation and high costs of manufacture. To overcome these problems, researchers have tried to develop mimics or peptidomimetics endowed with better properties, while retaining the basic features of membrane-active natural AMPs such as cationic charge and amphipathic design. Protein epitope mimetics, multimeric (dendrimeric) peptides, oligoacyllysines, ceragenins, synthetic lipidated peptides, peptoids and other foldamers are some of the routes explored so far. The synthetic approach has led to compounds that have already entered clinical evaluation for the treatment of specific conditions, such as Staphylococcus (MRSA) infections. Should these trials be successful, an important proof-of-concept would be established, showing that synthetic oligomers rather than naturally occurring molecules could bring peptide-based antibiotics to clinical practice and the drug market for local and systemic treatment of medical conditions associated with multi-drug resistant pathogens.
authors: Spider Biotech S.r.l, 10010, Colleretto Giacosa, TO, Italy.
authors: Andrea
authors: A
authors: Giuliani
authors: Andrea C
authors: AC
authors: Rinaldi
references: Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19375-80
references: 19880740
references: Antimicrob Agents Chemother. 2008 Sep;52(9):3118-26
references: 18606837
references: Nat Clin Pract Gastroenterol Hepatol. 2008 Jun;5(6):321-31
references: 18446147
references: J Bacteriol. 2005 Aug;187(15):5387-96
references: 16030233
references: Nat Biotechnol. 2007 Jun;25(6):657-9
references: 17529972
references: Drug Discov Today. 2008 Nov;13(21-22):944-51
references: 18725320
references: Cell Mol Life Sci. 2008 Aug;65(16):2450-60
references: 18661101
references: Antiviral Res. 2010 Mar;85(3):532-40
references: 20083141
references: Chemistry. 2009 Nov 2;15(43):11715-22
references: 19798715
references: Science. 2010 Feb 19;327(5968):1010-3
references: 20167788
references: J Am Chem Soc. 2009 Jul 22;131(28):9735-45
references: 19601684
references: Peptides. 2010 Aug;31(8):1459-67
references: 20438783
references: Curr Top Microbiol Immunol. 2006;306:231-50
references: 16909924
references: Future Microbiol. 2008 Aug;3(4):437-51
references: 18651815
references: FASEB J. 2010 Apr;24(4):1015-22
references: 19917670
references: Chemistry. 2009 Nov 9;15(44):11784-800
references: 19798714
references: FEMS Microbiol Lett. 2002 Nov 19;217(1):1-7
references: 12445638
references: Biochim Biophys Acta. 2009 Aug;1788(8):1582-92
references: 19028449
references: Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2794-9
references: 18287037
references: Chemotherapy. 2008;54(2):152-6
references: 18332629
references: Biochim Biophys Acta. 2007 Oct;1768(10):2500-9
references: 17599802
references: FEBS Lett. 1990 Nov 12;274(1-2):151-5
references: 2253768
references: Expert Rev Anti Infect Ther. 2007 Dec;5(6):951-9
references: 18039080
references: Curr Protoc Protein Sci. 2001 May;Chapter 18:Unit18.5
references: 18429141
references: Angew Chem Int Ed Engl. 2004 Feb 20;43(9):1158-62
references: 14983462
references: Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):15997-6002
references: 17038500
references: Antimicrob Agents Chemother. 2008 Dec;52(12):4308-14
references: 18838600
references: Appl Environ Microbiol. 2010 May;76(10):3301-7
references: 20363797
references: Chem Biol Drug Des. 2010 Jun;75(6):563-9
references: 20374251
references: J Invest Dermatol. 2009 Nov;129(11):2668-75
references: 19516269
references: J Mol Biol. 2008 May 23;379(1):38-50
references: 18440552
references: J Biol Chem. 2006 Apr 7;281(14):9432-8
references: 16407175
references: Curr Med Chem. 2009;16(1):42-65
references: 19149562
references: J Am Chem Soc. 2006 May 3;128(17):5776-85
references: 16637646
references: J Med Chem. 2008 Jul 24;51(14):4306-14
references: 18570363
references: Proc Natl Acad Sci U S A. 1988 Aug;85(15):5409-13
references: 3399498
references: Nat Rev Microbiol. 2005 Mar;3(3):238-50
references: 15703760
references: Biol Chem. 2001 Apr;382(4):597-619
references: 11405223
references: Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1354-8
references: 8433993
references: Chembiochem. 2010 Jan 25;11(2):152-60
references: 20017179
references: FASEB J. 2010 Jun;24(6):1904-13
references: 20124435
references: J Am Chem Soc. 2007 Dec 19;129(50):15474-6
references: 18034491
references: Biomacromolecules. 2008 Nov;9(11):2980-3
references: 18850741
references: J Am Chem Soc. 2004 Jun 9;126(22):6848-9
references: 15174837
references: J Am Chem Soc. 2006 Oct 11;128(40):13123-9
references: 17017792
references: Antimicrob Agents Chemother. 2005 Jul;49(7):2665-72
references: 15980334
references: J Am Chem Soc. 2007 Jan 17;129(2):417-28
references: 17212422
references: Philos Trans A Math Phys Eng Sci. 2010 Mar 13;368(1914):989-1008
references: 20123744
references: J Antimicrob Chemother. 2009 Jan;63(1):136-45
references: 19010828
references: BMC Microbiol. 2009 Sep 03;9:187
references: 19728885
references: Chem Biol Drug Des. 2007 Mar;69(3):216-21
references: 17441908
references: J Am Chem Soc. 2008 Aug 6;130(31):10338-44
references: 18624407
references: Oral Microbiol Immunol. 2009 Apr;24(2):170-2
references: 19239645
references: FASEB J. 2008 Aug;22(8):2652-61
references: 18385215
references: Curr Opin Biotechnol. 2008 Dec;19(6):620-7
references: 18996193